Literature DB >> 25610609

Pulmonary hypertension in POEMS syndrome: resolution following radiotherapy.

Melanie J Brewis1, Alistair C Church1, Andrew J Peacock1, Stephen Thomson1, Jane Tighe2, Martin K Johnson1.   

Abstract

Pulmonary hypertension (PH) is defined by the presence of a mean pulmonary artery pressure (mPAP) ≥25 mmHg. It may be idiopathic or arise as a consequence of a number of diverse conditions. PH has been reported in association with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes), with reversal following systemic treatment with corticosteroids. We report a case of pulmonary hypertension associated with POEMS syndrome treated with radical radiotherapy locally to bone lesions with resolution of systemic disease.

Entities:  

Keywords:  bosentan; plasmacytoma; sildenafil

Year:  2014        PMID: 25610609      PMCID: PMC4278633          DOI: 10.1086/678553

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  10 in total

1.  POEMS syndrome-related pulmonary hypertension is steroid-responsive.

Authors:  Pascale Jouve; Marc Humbert; Marie-Paule Chauveheid; Xavier Jaïs; Thomas Papo
Journal:  Respir Med       Date:  2006-06-13       Impact factor: 3.415

Review 2.  POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management.

Authors:  Angela Dispenzieri
Journal:  Am J Hematol       Date:  2011-07       Impact factor: 10.047

Review 3.  Pulmonary hypertension associated with POEMS syndrome.

Authors:  S Ribadeau-Dumas; I Tillie-Leblond; C Rose; F Saulnier; J L Wemeau; P Y Hatron; B Wallaert
Journal:  Eur Respir J       Date:  1996-08       Impact factor: 16.671

4.  POEMS syndrome: definitions and long-term outcome.

Authors:  Angela Dispenzieri; Robert A Kyle; Martha Q Lacy; S Vincent Rajkumar; Terry M Therneau; Dirk R Larson; Philip R Greipp; Thomas E Witzig; Rita Basu; Guillermo A Suarez; Rafael Fonseca; John A Lust; Morie A Gertz
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

5.  Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.

Authors:  Trista Stankowski-Drengler; Morie A Gertz; Jerry A Katzmann; Martha Q Lacy; Shaji Kumar; Nelson Leung; Suzanne R Hayman; Francis Buadi; Robert A Kyle; S Vincent Rajkumar; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

6.  Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension.

Authors:  Elaine Soon; Alan M Holmes; Carmen M Treacy; Natalie J Doughty; Laura Southgate; Rajiv D Machado; Richard C Trembath; Simon Jennings; Lucy Barker; Paul Nicklin; Christoph Walker; David C Budd; Joanna Pepke-Zaba; Nicholas W Morrell
Journal:  Circulation       Date:  2010-08-16       Impact factor: 29.690

7.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension.

Authors:  Christian Gerges; Mario Gerges; Marie B Lang; Yuhui Zhang; Johannes Jakowitsch; Peter Probst; Gerald Maurer; Irene M Lang
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

8.  Pulmonary hypertension in POEMS syndrome.

Authors:  Jian Li; Zhuang Tian; Hao-Yi Zheng; Wei Zhang; Ming-Hui Duan; Yong-Tai Liu; Xin-Xin Cao; Dao-Bin Zhou
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

9.  Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients.

Authors:  Joanne Shirine Allam; Cassie C Kennedy; Timothy R Aksamit; Angela Dispenzieri
Journal:  Chest       Date:  2008-01-15       Impact factor: 9.410

10.  Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.

Authors:  Yukari Sekiguchi; Sonoko Misawa; Kazumoto Shibuya; Saiko Nasu; Satsuki Mitsuma; Yuta Iwai; Minako Beppu; Setsu Sawai; Shoichi Ito; Shigeki Hirano; Chiaki Nakaseko; Satoshi Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-05       Impact factor: 10.154

  10 in total
  3 in total

1.  Polyneuropathy as Novel Initial Manifestation in a Case of "Nonsecretory" POEMS Syndrome with Sjögren's Syndrome.

Authors:  Minrui Liang; Zhixing Jiang; Zhiguang Lin; Bobin Chen; Hejian Zou; Weiguo Wan; Jun Liu
Journal:  Case Rep Med       Date:  2017-01-04

2.  Plexogenic pulmonary hypertension associated with POEMS syndrome.

Authors:  Thomas Czeczok; Peter Lin; Eunhee Yi
Journal:  Respir Med Case Rep       Date:  2017-08-12

Review 3.  POEMS SYNDROME: an Update.

Authors:  Andrea Nozza
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.